GlassScriptPhysician profile
Sheldon K Cho
NPI 1003885831
$1,449.83
in general payments reported to CMS, 2019-2025
15 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,071 · 2020: $321 · 2022: $58.08.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nevro Corp. | $333.76 | 2019 | |
| Medtronic USA, INC. | $295.61 | 2019-2020 | |
| Allergan, INC. | $170.87 | 2019-2020 | |
| Djo, LLC | $135.31 | 2020 | |
| Biodelivery Sciences International, INC. | $133.74 | 2019 | |
| Alkermes, INC. | $92.75 | 2019 | |
| Abbott Laboratories | $78.98 | 2019-2020 | |
| Scilex Pharmaceuticals INC. | $56.40 | 2019-2020 | |
| Medtronic, INC. | $30.04 | 2022 | |
| Surgalign Spine Technologies, INC. | $28.04 | 2022 | |
| Novartis Pharmaceuticals Corporation | $25.65 | 2019-2020 | |
| Pacira Therapeutics, INC. | $24.49 | 2020 | |
| Collegium Pharmaceutical, INC. | $21.62 | 2019 | |
| Antares Pharma, INC. | $12.25 | 2019 | |
| Stimwave Technologies Incorporated | $10.32 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sheldon Cho listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.